LENZ Therapeutics Statistics Share Statistics LENZ Therapeutics has 28.52M
shares outstanding. The number of shares has increased by 3.71%
in one year.
Shares Outstanding 28.52M Shares Change (YoY) 3.71% Shares Change (QoQ) 1.34% Owned by Institutions (%) 88.06% Shares Floating 24.18M Failed to Deliver (FTD) Shares 645 FTD / Avg. Volume 0.13%
Short Selling Information The latest short interest is 5.02M, so 17.6% of the outstanding
shares have been sold short.
Short Interest 5.02M Short % of Shares Out 17.6% Short % of Float 32.6% Short Ratio (days to cover) 13.52
Valuation Ratios The PE ratio is -12.34 and the forward
PE ratio is -19.02.
LENZ Therapeutics's PEG ratio is
0.15.
PE Ratio -12.34 Forward PE -19.02 PS Ratio 0 Forward PS 28 PB Ratio 3.01 P/FCF Ratio -10.26 PEG Ratio 0.15
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for LENZ Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 20.36,
with a Debt / Equity ratio of 0.01.
Current Ratio 20.36 Quick Ratio 20.36 Debt / Equity 0.01 Debt / EBITDA -0.03 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-8.29M Employee Count 6 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 1K Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 89.06% in the
last 52 weeks. The beta is 0.49, so LENZ Therapeutics's
price volatility has been higher than the market average.
Beta 0.49 52-Week Price Change 89.06% 50-Day Moving Average 38.73 200-Day Moving Average 30.02 Relative Strength Index (RSI) 70.59 Average Volume (20 Days) 491,528
Income Statement
Revenue n/a Gross Profit -58K Operating Income -58.61M Net Income -49.77M EBITDA -49.71M EBIT -49.77M Earnings Per Share (EPS) -2.34
Full Income Statement Balance Sheet The company has 20.16M in cash and 1.38M in
debt, giving a net cash position of 18.78M.
Cash & Cash Equivalents 20.16M Total Debt 1.38M Net Cash 18.78M Retained Earnings -145.01M Total Assets 217.33M Working Capital 203.2M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -59.39M
and capital expenditures -468K, giving a free cash flow of -59.86M.
Operating Cash Flow -59.39M Capital Expenditures -468K Free Cash Flow -59.86M FCF Per Share -2.81
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields LENZ does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for LENZ is $52,
which is 6.7% higher than the current price. The consensus rating is "Strong Buy".
Price Target $52 Price Target Difference 6.7% Analyst Consensus Strong Buy Analyst Count 4
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 22, 2024. It was a
backward
split with a ratio of 1:7.
Last Split Date Mar 22, 2024 Split Type backward Split Ratio 1:7
Scores Altman Z-Score 63.46 Piotroski F-Score 3
